| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 114.91M | 107.45M | 101.01M | 126.56M | 126.01M | 134.19M |
| Gross Profit | 33.10M | 30.85M | 23.31M | 27.62M | 29.01M | 27.54M |
| EBITDA | 12.57M | 11.06M | 2.60M | 10.07M | 9.15M | 9.44M |
| Net Income | 4.33M | 2.51M | -1.62M | 4.58M | 3.81M | 3.73M |
Balance Sheet | ||||||
| Total Assets | 69.09M | 68.49M | 70.74M | 80.37M | 105.89M | 80.03M |
| Cash, Cash Equivalents and Short-Term Investments | 14.47M | 19.44M | 20.10M | 15.32M | 17.63M | 22.33M |
| Total Debt | 535.00K | 6.67M | 15.51M | 25.49M | 25.82M | 28.34M |
| Total Liabilities | 40.20M | 43.32M | 47.92M | 56.06M | 84.32M | 60.59M |
| Stockholders Equity | 28.90M | 25.17M | 22.81M | 24.30M | 21.57M | 19.44M |
Cash Flow | ||||||
| Free Cash Flow | 8.90M | 13.24M | 13.26M | 297.00K | 1.35M | 9.29M |
| Operating Cash Flow | 10.36M | 14.21M | 14.07M | 1.39M | 3.60M | 10.74M |
| Investing Cash Flow | -1.45M | -928.00K | -724.00K | 531.00K | -1.47M | -1.45M |
| Financing Cash Flow | -14.08M | -10.39M | -11.85M | -4.08M | -6.79M | -15.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$344.60M | 10.02 | 4.39% | 10.62% | -0.88% | 7.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | HK$2.79B | 82.46 | 15.73% | 0.33% | 11.29% | 40.42% | |
54 Neutral | €289.57M | -8.02 | -6.99% | 10.45% | -6.75% | -310.42% | |
46 Neutral | HK$209.10M | -9.65 | -4.14% | ― | 3.70% | 5.90% | |
45 Neutral | HK$598.10M | ― | -16.40% | 4.61% | 0.48% | -86.42% | |
45 Neutral | HK$184.09M | ― | -8.93% | ― | -59.19% | -159.11% |
Home Control International Limited has announced a high concentration of its shareholding in the hands of a limited number of shareholders, as revealed by a recent enquiry by the Securities and Futures Commission (SFC). As of October 17, 2025, 91.61% of the company’s shares were held by a small group, including a substantial shareholder, Meta-Wisdom Tech Limited. This concentration could lead to significant price fluctuations, as evidenced by the share price rising 561% from June to November 2025. Stakeholders are advised to exercise caution due to the potential volatility in share prices.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
The Securities and Futures Commission (SFC) has announced a high concentration of shareholding in Home Control International Limited, with a small number of shareholders holding a significant portion of the company’s shares. As of October 17, 2025, 91.61% of the issued shares were held by a substantial shareholder and a group of 20 shareholders, leaving only 8.39% for other shareholders. This concentration could lead to substantial price fluctuations, as evidenced by the share price increase of 561% from June to November 2025, prompting the SFC to advise caution for current and prospective investors.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
Home Control International Limited has established a wholly-owned subsidiary, Orbiva Limited, in Hong Kong to spearhead its strategic expansion into the healthcare sector. This move is part of the company’s broader strategy to develop an AIoT-enabled home healthcare platform and ecosystem, integrating hardware, software, data, and services. Orbiva Limited will focus on creating intelligent healthcare products and services, aiming to build a comprehensive digital health management system. The company is also exploring partnerships with universities and fintech institutions to enhance its technological and operational capabilities.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
Home Control International Limited has announced the incorporation of a wholly-owned subsidiary in Hong Kong as part of its strategic expansion into the healthcare sector. This move aims to leverage the company’s expertise in home-control solutions to develop a comprehensive health-services ecosystem, focusing on home-care scenarios and innovative healthcare operations. The initiative aligns with global trends of population aging and rising chronic diseases, and the company has already seen preliminary success with healthcare solutions accounting for 19.7% of its total revenue in the first half of 2025.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
Home Control International Limited has announced the appointment of Mr. Min Ye and Mr. Yi Chung Chen as independent non-executive directors, effective from September 3, 2025. Mr. Ye brings over 30 years of experience in credit analysis, capital markets, and risk management, while Mr. Chen has over 20 years of experience in corporate management and investment. These appointments are expected to enhance the company’s strategic direction and financial innovation initiatives.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
Home Control International Limited has announced the composition of its board of directors and the roles within its board committees. This update highlights the company’s governance structure, which is crucial for maintaining transparency and accountability, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1747) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Home Control International Limited stock, see the HK:1747 Stock Forecast page.
Home Control International Limited announced its unaudited interim results for the six months ended June 30, 2025, showing a revenue increase to US$59.6 million from US$52.1 million in the same period of 2024. The company reported a gross profit of US$17.7 million and a net profit attributable to owners of US$5.0 million, reflecting a significant improvement from the previous year. The positive financial performance highlights the company’s strong market positioning and operational efficiency, benefiting stakeholders and enhancing its competitive edge in the remote control technology sector.